Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ (140,651) $ (141,079)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 33,924 20,227
Amortization of debt issuance costs and discount 779 1,436
Equity-based compensation expense 56,945 47,591
Loss on extinguishment of debt 3,731 0
(Gain) loss on change in fair value of warrants 14,147 (11,506)
Deferred provision (benefit) for income taxes 2,008 (25,965)
Purchase accounting fair value adjustment related to inventory 0 13,645
Other 3,706 (2,084)
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 8,108 1,595
(Increase) decrease in contract assets (41,199) (5,562)
(Increase) decrease in inventory (45,606) (3,937)
(Increase) decrease in prepaid expenses and other assets (3,652) (3,617)
Increase (decrease) in accounts payable and accrued expenses 12,914 (9,772)
Increase (decrease) in deferred revenue 10,681 (34,094)
Increase (decrease) in operating lease liabilities (369) (141)
Increase (decrease) in other liabilities (11,658) 194
Increase (decrease) in notes payable to sellers 1,000 0
Net cash provided by (used in) operating activities (95,192) (153,069)
Cash flows from investing activities:    
Acquisition of businesses, net of cash acquired 0 (151,791)
Purchases of property, plant and equipment (15,040) (11,288)
Purchase of intangible assets (4,165) (6,139)
Net cash provided by (used in) investing activities (19,205) (169,218)
Cash flows from financing activities:    
Proceeds received from debt 89,728 191,238
Repayments of debt (130,662) (127,196)
Payment of debt issuance fees (1,914) (105)
Repayment of finance leases (475) (379)
Proceeds from (repayment of) third-party advances 0 (7,820)
Proceeds from issuance of common stock 566,670 337,806
Payment of equity issuance costs (14,031) 0
Proceeds from common stock issued for options exercise 4,155 0
Shares repurchased for settlement of employee tax withholdings on share-based awards (965) (2,763)
Convertible preferred stock dividend (3,358) 0
Repurchase of convertible preferred stock 0 (63,862)
Net cash provided by (used in) financing activities 509,148 326,919
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash (1,068) 625
Net increase (decrease) in cash, cash equivalents and restricted cash 393,683 5,257
Cash, cash equivalents and restricted cash at beginning of period 95,183 49,071
Cash, cash equivalents and restricted cash at end of period $ 488,866 $ 54,328